Evidence map›Paper›PMID 34745007›Full record

ArticleFrontiers in endocrinology2021

Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB

Viktória B Horváth, Eszter Soltész-Katona, Éva Wisniewski, Anikó Rajki, Eszter Halász, Balázs Enyedi, László Hunyady, András Dávid Tóth, Gergő Szanda

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Hepatic CB1 receptor signaling triggers GMetabolism: clinical and experimental · 2025
    Article
  2. Cannabinoid Receptor Signaling is Dependent on Sub-Cellular Location.bioRxiv : the preprint server for biology · 2024
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Viktória B HorváthDepartment of Physiology, Semmelweis University, Budapest, Hungary.
Eszter Soltész-KatonaDepartment of Physiology, Semmelweis University, Budapest, Hungary.
Éva WisniewskiDepartment of Physiology, Semmelweis University, Budapest, Hungary.
Anikó RajkiDepartment of Physiology, Semmelweis University, Budapest, Hungary.
Eszter HalászDepartment of Physiology, Semmelweis University, Budapest, Hungary.
Balázs EnyediDepartment of Physiology, Semmelweis University, Budapest, Hungary.
László HunyadyDepartment of Physiology, Semmelweis University, Budapest, Hungary.
András Dávid TóthMTA-SE Laboratory of Molecular Physiology, Eötvös Loránd Research Network, Budapest, Hungary.
Gergő SzandaDepartment of Physiology, Semmelweis University, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The G protein-coupled type 1 cannabinoid receptor (CB

Indexed as

Cell LineEndoplasmic Reticulum StressHumansMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 3p38 Mitogen-Activated Protein KinasesPromoter Regions, GeneticProteasome Endopeptidase ComplexReceptor, Cannabinoid, CB1Receptors, G-Protein-CoupledRNA, Small InterferingMAPK3 protein, humanMitogen-Activated Protein Kinase 3p38 Mitogen-Activated Protein KinasesProteasome Endopeptidase ComplexReceptor, Cannabinoid, CB1Receptors, G-Protein-CoupledRNA, Small InterferingcannabinoidsCB1 receptorheterologous expressionnon-canonical signalingreceptor degradationweak promoters

Identifiers

PMID34745007
PMCPMC8564136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.